Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -1 632% | 6.66% | -15.3% | -55.9% | -93.4% | -160.5% | ||
| Changes by years, y/y, % | -891pp | +1 638pp | -22pp | -41pp | -37pp | -33.9% | |||
Arcturus Therapeutics Holdings. EBITDA margin, %
Arcturus Therapeutics Holdings. EBITDA margin, changes, pp
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -54.5% | -34.3% | -74.0% | -653.7% | -4 312% | -160.5% | |
| Changes by years, y/y, % | +36pp | +10pp | -58pp | -515pp | -4 258pp | |||
| Changes by quarters, q/q, % | +84pp | +20pp | -40pp | -580pp | -3 659pp | |||
